TUDCA given ALS sufferers at upper dose observed to increase survival
Other folks with amyotrophic lateral sclerosis (ALS) who’re handled day-to-day with 1,000 mg or upper doses of tauroursodeoxycholic acid (TUDCA) have a tendency to outlast the ones given same old care on